Join
Live feed
·
INSIDERFilingvia Quantisnow
Adaptimmune Therapeutics plc logo

SEC Form 4: Rawcliffe Adrian sold $1,874 worth of American Depositary Shares representing Ordinary Shares (2,403 units at $0.78), decreasing direct ownership by 41% to 3,449 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADAP (Adaptimmune Therapeutics plc) and more on Quantisnow.